The type of oral corticosteroid — prednisolone or dexamethasone — used to treat pediatric patients with croup appears to have no clinically significant effect on efficacy.
In patients with malignant pleural effusion, elevated pleural elastance and incomplete lung expansion are frequently observed after thoracentesis.
Adult cases of aspiration examined via chest computed tomography scan and video-swallow evaluation yielded a broad spectrum of clinicoradiologic presentations.
For the diagnosis of small peripheral pulmonary lesions, a 3.0-mm ultrathin bronchoscope provides a higher diagnostic yield than a 4.0-mm thin bronchoscope.
Military personnel deployed to Afghanistan and Southwest Asia experience a complex mixture of exposures, most notably PM2.5 from desert dust, which can lead to adverse respiratory effects.
In patients with ischemic penumbra and blood-brain barrier disruption, hyperoxygenation therapy may mitigate ischemia and remove air.
The guideline addresses laboratory testing for diagnosis of fungal infections in pulmonary medicine and critical care.
The highest survival was seen with the induction maintenance combination of sirolimus plus tacrolimus without induction therapy.
Orvepitant treatment in intractable chronic refractory cough has demonstrated clinically relevant and sustained improvements in cough frequency and quality of life.
Among patients with aspirin-exacerbated respiratory disease, there appears to be a gradual progression from asthma to nasal polyps and then to aspirin sensitivity.
A dedicated diagnostic algorithm has been proposed for suspected pulmonary embolism in pregnancy.
Ventricular dysfunction that occurs in newborns within 48 hours of life with congenital diaphragmatic hernia is common and may represent an independent indicator of disease severity and associated survival.
A bronchodilator response grading system can identify differences in exercise performance, exacerbation frequency, and dyspnea in people who smoke or who have a prior smoking history.
The safety and efficacy profile from this study supports the role of dupilumab as continuous long-term treatment for patients with moderate to severe atopic dermatitis.
Cutaneous comorbidity is frequent in those with atopic dermatitis, suggesting the need for comprehensive, dermatologically guided diagnostics.